Home - JDNPPA

Catching Up With Past and Present Beiersdorf Residents of Distinction

Advertisement

Big News: U.S. FDA Approves ZEVASKYN, the First and Only FDA-approved Product for Recessive Dystrophic Epidermolysis Bullosa

April 29, 2025

CMS Grants Permanent Product-specific Q-Code for Fresenius Kabi’s Stelara Biosimilar

April 29, 2025

Three Things to Know This Rosacea Awareness Month With Dr. Julie C. Harper

April 24, 2025

New Survey Data: Chronic Hand Eczema Affects Patients’ Emotional, Social and Occupational Well-Being

April 22, 2025

Advertisement

Turning Points in Treating Vitiligo: The Patient Journey

Prescribing Hope: Exploring What’s Possible with Topical JAK Inhibition in Vitiligo

Grand Rounds: Atopic Dermatitis

Raising the Bar in Atopic Dermatitis: Unpacking the practice-changing implications of the LEVEL UP study in AD

The Blend, Episode 1: Integrative Dermatology 101

Advertisement

Latest Issue

Latest Supplement

Advertisement

Digital Edition Archive